InvestorsHub Logo

sox040713

11/27/14 2:10 AM

#79808 RE: BonelessCat #79806

Yup, my guess would be pancreatic and ovarian cancer. Throw in retinoblastoma and the two combo trials against AML and renal cancer, it is possible that CTIX has five K trials up and running within one year. Oh my!